IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 413.62 USD 0.11%
Market Cap: 33.9B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one IDXX stock under the Base Case scenario is 308.86 USD. Compared to the current market price of 413.62 USD, IDEXX Laboratories Inc is Overvalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDXX Relative Value
Base Case
308.86 USD
Overvaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.9
P/S
P/S
Price to Sales
8.9
vs History
93
vs Industry
13
Median 3Y
11.1
Median 5Y
11.6
Industry
2.3
Forward
8.6
More Details
39.3
P/E
P/E
Price to Earnings
39.3
vs History
98
vs Industry
10
Median 3Y
50
Median 5Y
54.5
Industry
23.1
Forward
38.6
More Details
37.1
P/OCF
P/OCF
Price to OCF
37.1
vs History
98
vs Industry
8
Median 3Y
51.8
Median 5Y
56.6
Industry
14.2
More Details
53
P/FCFE
P/FCFE
Price to FCFE
53
vs History
73
vs Industry
8
Median 3Y
68.5
Median 5Y
81.2
Industry
20.1
More Details
21
P/B
P/B
Price to Book Value
21
vs History
98
vs Industry
2
Median 3Y
46.4
Median 5Y
65.6
Industry
2.2
More Details
9
EV/S
EV/S
Enterprise Value to Sales
9
vs History
95
vs Industry
12
Median 3Y
11.3
Median 5Y
11.9
Industry
2.4
Forward
8.7
More Details
14.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
14.8
vs History
95
vs Industry
10
Median 3Y
19.1
Median 5Y
20
Industry
5
More Details
31
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
31
vs History
92
vs Industry
9
Median 3Y
36.2
Median 5Y
38.3
Industry
12.7
Forward
26.2
More Details
31
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
31
vs History
96
vs Industry
11
Median 3Y
40
Median 5Y
43
Industry
17.1
Forward
30
More Details
37.6
EV/OCF
EV/OCF
Enterprise Value to OCF
37.6
vs History
98
vs Industry
8
Median 3Y
53.3
Median 5Y
58
Industry
14
More Details
43.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
43.5
vs History
98
vs Industry
9
Median 3Y
69.4
Median 5Y
76.1
Industry
18
More Details
11.8
EV/IC
EV/IC
Enterprise Value to IC
11.8
vs History
96
vs Industry
6
Median 3Y
15.5
Median 5Y
16.2
Industry
1.9
More Details

Multiples Across Competitors

IDXX Competitors Multiples
IDEXX Laboratories Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34B USD 8.9 39.3 31 31
US
Abbott Laboratories
NYSE:ABT
199B USD 4.8 34.5 20 29.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.3B USD 24.3 85.3 72.8 90.4
US
Stryker Corp
NYSE:SYK
141.3B USD 6.4 39.4 25.6 31
US
Boston Scientific Corp
NYSE:BSX
134.2B USD 8.4 74.8 34.3 49
IE
Medtronic PLC
NYSE:MDT
104.6B USD 3.2 24.4 13.6 19.3
US
Becton Dickinson and Co
NYSE:BDX
65.6B USD 3.3 38 15.7 28.2
DE
Siemens Healthineers AG
XETRA:SHL
58.1B EUR 2.6 31.2 17.7 25.8
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 7.9 10.7 23.8 26.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
311.1B CNY 8.4 25.1 21.8 21.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.3B USD 1.9 21.6 13.6 16.7

See Also

Summary
IDXX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDXX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDXX stock valuation using valuation multiples.
Wall Street Estimates
IDXX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDXX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.